Showing 2061-2070 of 3832 results for "".
- Murad Alam, MD, FAAD, Elected American Academy of Dermatology President for 2026https://modernaesthetics.com/news/murad-alam-md-faad-elected-american-academy-of-dermatology-president-for-2026/2473558/Chicago-based board-certified dermatologist Murad Alam, MD, FAAD, has been elected to lead the American Academy of Dermatology (AAD). He will be installed as president-elect in March 2025 and hold the office of president for 1 year beginning in March 2026. AAD is the world’s large
- Letybo (letibotulinumtoxinA-wlbg) Receives FDA Approvalhttps://modernaesthetics.com/news/fda-grants-approval-for-letybo-letibotulinumtoxina-wlbg/2473551/Hugel America, Inc., announced the achievement of a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its neurotoxin, Letybo. "We are thrilled with the FDA's approval of Letybo. This is a huge achievement for Hugel as we
- Eucerin Introduces First Face Care Collection With Multi-Weight Hyaluronic Acid Technologyhttps://modernaesthetics.com/news/eucerin-introduces-first-face-care-collection-with-multi-weight-hyaluronic-acid-technology/2473544/Hitting shelves January 2024, Eucerin's Immersive Hydration Collection is a new entry into the face-care category with a unique, multi-weight hyaluronic acid formulation. A first to pioneer this technology across a full face care regimen* to intensively hydrate skin and visibly smoo
- Industry Vet Matthew Hill Named CFO at Apyx Medical Corporationhttps://modernaesthetics.com/news/industry-vet-matthew-hill-named-cfo-at-apyx-medical-corporation/2473534/Matthew Hill is Apyx Medical Corporation’s (new Chief Financial Officer (CFO), effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. “With its innovative Renuvion technology, large, global m
- AestheticsWire Exclusive: Embracing Diversity in Aestheticshttps://modernaesthetics.com/news/embracing-diversity-in-aesthetics/2473528/There’s no such thing as a one-size-fits-all approach to rejuvenation as people across genders, ethnicities, and age groups often have different concerns and aesthetic goals. This is the main takeaway from a new study that sought to better understand facial and body aesthetic conc
- Revance Taps Erica Jordan as CCOhttps://modernaesthetics.com/news/revance-taps-erica-jordan-as-coo/2473522/Erica Jordan is now Revance Therapeutics, Inc.’s Chief Commercial Officer (CCO), Aesthetics. “Given the importance of the DAXXIFY launch, I’m excited to elevate Erica to the position of Chief Commercial Officer, Aesthetics reporting directly to me. Having wo
- AirSculpt Technologies Teams Up NYSYNC Member Joey Fatonehttps://modernaesthetics.com/news/airsculpt-technologies-teams-up-nysync-member-joey-fatone/2473508/AirSculpt Technologies, Inc. is partnering with singer, dancer, actor Joey Fatone to share his AirSculpt experience. AirSculpt is a liposuction procedure that removes fat and tightens skin. It’s offered exclusively at Elite Body Sculpture centers.
- Industry Vet Aaron Green Joins RepeatMDhttps://modernaesthetics.com/news/industry-vet-aaron-green-joins-repeatmd/2473498/Aaron Green is RepeatMD’s new Vice President of Business Development. RepeatMD is a mobile shopping platform that integrates ecommerce and fintech solutions, providing aesthetic and wellness practices with a personalized shopping experience for their patients. &quo
- Dr. Ashley Brissette Is Clinique’s First Guiding Ophthalmologisthttps://modernaesthetics.com/news/nyc-ophthalmologist-dr-ashley-brissette-is-cliniques-first-guiding-ophthalmologist/2473481/NYC-based ophthalmologist Ashley Brissette, MD, MSc, FRCSC, is Clinique’s first guiding ophthalmologist. In the newly created role, Dr. Brissette will help educate consumers on the importance of eye safety, help guide the development of new products, and contribute to C
- Delnova Demonstrates Proof of Concept for ReViVoxhttps://modernaesthetics.com/news/delnova-demonstrates-proof-of-concept-for-revivox/2473478/Delnova’s ReViVox showed reversal or muscle paralysis or weakness in a small cohort of healthy subjects. ReViVox is being developed to resolve side effects that may result from botulinum neurotoxin treatments. In the proof-of-concept study, volunteer subj